title: [Is famotidine--the 3d generation H2 receptor antagonist--a step in progress in the treatment of duodenal ulcer?].
authors.forename: J
authors.initials: J
authors.lastname: Stasiewicz
authors.forename: J
authors.initials: J
authors.lastname: Romatowski
authors.forename: A
authors.initials: A
authors.lastname: Kluz
authors.forename: W
authors.initials: W
authors.lastname: Szałaj
authors.forename: Z
authors.initials: Z
authors.lastname: Namiot
mesh_terms: D000328:Adult; D000368:Aged; D055598:Chemical Phenomena; D002621:Chemistry; D002927:Cimetidine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004381:Duodenal Ulcer / Q000188:drug therapy*; D015738:Famotidine / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011899:Ranitidine / Q000627:therapeutic use; D014945:Wound Healing / Q000187:drug effects
chemical_list: D015738:Famotidine; D002927:Cimetidine; D011899:Ranitidine
vernacular_title: Czy famotydyna--antagonista receptorów H2 III generacji--stanowi dalszy postep w leczeniu wrzodu dwunastnicy?